Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UK P3BEP: Accelerated vs standard BEP for metastatic germ cell tumours
2015-003060-37Phase 3Unknown
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bleomycin, etoposide and cisplatin (2 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Progression-free survival. Status: unknown.
02
Drugs
bleomycinetoposidecisplatin
Beyond the preview
Go deeper on 2015-003060-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003060-37.